Replies to post #3281 on Theralase Technologies Inc (TLTFF)

[JMoriarty]

that was for the first 3 only.. just to note *smirk*

[123414]

We describe TLD-1433 clinical timelines embedded in our financial forecasts that we derive below, but as a key takeaway, we believe that TLD-1433 could be FDA-approved and launched by FH222 under best-base scenario, assuming that pivotal US testing begins by FH219 and that one-year recurrence free survival (RFS) data are available by FH122. (pg 1)

Bladder cancer-targeted PDT TLD-1433 is a major value driver in our model


http://67.212.93.22/research/content/20170905TLT%20final.pdf
*******************************************************************

Theralase Successfully Completes Phase Ib Non-Muscle Invasive Bladder Cancer Clinical Study

https://www.fscwire.com/newsrelease/theralase-successfully-completes-phase-ib-non-muscle-invasive-bladder-cancer-clinical
**********************************************************************

The Company is planning to meet with Health Canada and FDA, to discuss and finalize the design of a Health Canada and FDA pivotal Phase II NMIBC clinical study, with a primary endpoint of efficacy.


https://app.quotemedia.com/quotetools/newsStoryPopup.go?storyId=6776145775401349&topic=TLTFF&symbology=null&cp=null&webmasterId=90338
**********************************************************************


________________________________________________________________________


We are on track to meet or modestly exceed the analysts expectations.


Further, please note the supportive warrant and options that have proven very supportive of the company's finances in the past year.

Warrants and option outstanding.
Current outstanding shares- 131,585,526
5,104,000 warrants at 30 cents
14,236,666 warrants at 38 cents
18,181,817 warrants at 54 cents
10,310,000 options at 50 cents
fully diluted 179,418,009

Combined would bring in almost $22 million CAD. Probably enough to fund Ph2. Like I mentioned earlier we should already by around $6 considering there won't be a Ph3. There shouldn't be anymore dilution imo.

http://www.stockhouse.com/companies/bullboard?symbol=v.tlt&postid=28101154